Peripheral Neuropathy Secondary to Diabetes: VA Disability Claim Guide

Overview

Peripheral neuropathy — damage to the nerves outside the brain and spinal cord, typically affecting the hands and feet — is the most common complication of diabetes mellitus and one of the most frequently granted secondary conditions in the VA disability system. The relationship between diabetes and peripheral neuropathy is so well-established that VA raters routinely expect diabetic veterans to develop neuropathy over time.

Under 38 CFR § 3.310, veterans with service-connected diabetes can claim peripheral neuropathy as a secondary condition when the nerve damage is caused by their diabetic condition. The VA’s own rating criteria for diabetes mellitus (DC 7913) specifically note that complications of diabetes, including neurological conditions, should be separately evaluated.

Because each affected extremity receives its own rating, diabetic peripheral neuropathy can significantly increase a veteran’s combined disability rating. A veteran with neuropathy in all four extremities could receive four separate ratings, making this one of the most impactful secondary claims available.

How Peripheral Neuropathy Is Connected to Diabetes

The medical relationship between diabetes and peripheral neuropathy is one of the most thoroughly researched connections in all of medicine. Diabetic peripheral neuropathy (DPN) develops through several well-understood pathological mechanisms:

Metabolic nerve damage. Chronically elevated blood glucose levels trigger a cascade of metabolic changes that directly damage peripheral nerves. The polyol pathway — in which excess glucose is converted to sorbitol by the enzyme aldose reductase — causes osmotic stress and oxidative damage to nerve cells. Research published in the New England Journal of Medicine identified this mechanism as a primary driver of diabetic neuropathy.

Microvascular disease. Diabetes damages the vasa nervorum — the tiny blood vessels that supply oxygen and nutrients to peripheral nerves. When these vessels become diseased, the nerves they supply are deprived of adequate blood flow, leading to ischemic nerve injury. A study in Diabetes Care demonstrated that microvascular disease in the vasa nervorum precedes and correlates with the development of neuropathic symptoms.

Advanced glycation end products (AGEs). High blood sugar promotes the formation of AGEs, which accumulate in nerve tissue and cause structural and functional damage. Research in Diabetologia has shown that AGE accumulation in peripheral nerves correlates with neuropathy severity.

Prevalence data is striking. The American Diabetes Association reports that approximately 50% of people with diabetes develop peripheral neuropathy during their lifetime. A prospective study in Diabetes Care followed diabetic patients for 25 years and found that neuropathy prevalence increased from 8% at diagnosis to 50% after 25 years of diabetes, demonstrating the progressive and time-dependent nature of the condition.

Distal symmetric polyneuropathy is the most common pattern, affecting the longest nerves first. This explains why symptoms typically begin in the toes and feet and gradually progress upward (a “stocking-glove” distribution). Research in The Lancet Neurology confirmed that this length-dependent pattern is the hallmark of diabetic peripheral neuropathy.

The Diabetes Control and Complications Trial (DCCT) — one of the most important studies in diabetes research — definitively proved that glycemic control directly affects neuropathy risk, establishing the causal relationship between blood sugar levels and nerve damage.

Evidence Requirements

To establish secondary service connection for peripheral neuropathy, you need clear documentation of both the condition and its link to diabetes:

• Current peripheral neuropathy diagnosis: A formal diagnosis from a neurologist or your treating physician specifying the type (sensory, motor, or sensorimotor) and distribution (which extremities are affected).
• Nerve conduction study (NCS) or electromyography (EMG): Electrodiagnostic testing that objectively documents nerve damage, identifies affected nerves, and quantifies severity. These tests are particularly valuable because they provide measurable data the VA can use to determine rating levels.
• Service-connected diabetes mellitus documentation: Your VA rating decision confirming diabetes mellitus type II is service-connected.
• HbA1c records: Hemoglobin A1c test results over time. These demonstrate your blood sugar control history and help establish that chronic hyperglycemia contributed to nerve damage. Elevated HbA1c levels support the diabetes-neuropathy nexus.
• Medical nexus letter: A physician’s opinion linking your peripheral neuropathy to your service-connected diabetes through the established metabolic and microvascular mechanisms.
• Treatment records: Documentation of neuropathy symptoms, prescriptions for neuropathic pain medications (gabapentin, pregabalin, duloxetine, amitriptyline), physical therapy, and any diabetic foot care.
• Neuropathy symptom documentation: Records describing numbness, tingling, burning pain, loss of sensation, muscle weakness, balance problems, and any falls or injuries resulting from neuropathy.
• Monofilament testing results: If your doctor has performed Semmes-Weinstein monofilament testing (a standard screening for diabetic neuropathy), these results provide additional objective evidence.

Nexus Letter Tips

The nexus between diabetes and peripheral neuropathy is one of the most medically straightforward connections. The nexus letter can be clear and direct.

Who should write it: A neurologist, endocrinologist, or primary care physician who manages your diabetes. Because the connection is so well-established, any physician familiar with your case can write an effective letter.

What it should say: The letter must state that your peripheral neuropathy is “at least as likely as not” caused by your service-connected diabetes mellitus. Specifically:

1. State the provider’s credentials and relevant expertise
2. Confirm they reviewed your medical records, including HbA1c history and electrodiagnostic testing
3. Document your peripheral neuropathy diagnosis, specifying affected extremities and type (sensory, motor, or mixed)
4. Explain the established mechanisms — metabolic nerve damage from chronic hyperglycemia, microvascular disease affecting the vasa nervorum, and AGE accumulation
5. Reference your HbA1c history showing periods of elevated blood sugar
6. Note that your neuropathy follows the classic distal symmetric pattern consistent with diabetic etiology
7. Cite the established medical literature (ADA guidelines, DCCT results)
8. Use the correct legal standard: “at least as likely as not”
9. If applicable, address and rule out other potential causes of neuropathy (alcohol use, vitamin deficiencies, other toxic exposures)

Strength of this claim: The ADA itself states that diabetes is the most common cause of peripheral neuropathy in the developed world. A nexus letter citing this authoritative source, combined with your personal HbA1c history and electrodiagnostic results, creates an exceptionally strong evidentiary package.

Rating Criteria for Peripheral Neuropathy

The VA rates peripheral neuropathy under the diagnostic codes for the specific nerves affected. For lower extremity neuropathy, the most common codes are:

DC 8520 — Paralysis of the Sciatic Nerve (lower extremity):

• 10% — Mild incomplete paralysis
• 20% — Moderate incomplete paralysis
• 40% — Moderately severe incomplete paralysis
• 60% — Severe incomplete paralysis with marked muscular atrophy
• 80% — Complete paralysis

DC 8515 — Paralysis of the Median Nerve (upper extremity, dominant):

• 10% — Mild incomplete paralysis
• 30% — Moderate incomplete paralysis (dominant hand)
• 50% — Severe incomplete paralysis (dominant hand)
• 70% — Complete paralysis (dominant hand)

DC 8515 — Paralysis of the Median Nerve (upper extremity, non-dominant):

• 10% — Mild incomplete paralysis
• 20% — Moderate incomplete paralysis
• 40% — Severe incomplete paralysis
• 60% — Complete paralysis

How severity is determined for diabetic neuropathy:

• Mild (10%): Predominantly sensory symptoms — numbness, tingling, intermittent burning pain. Minimal or no motor involvement. Nerve conduction studies show mild abnormalities.
• Moderate (20%): Sensory symptoms plus measurable motor deficits — reduced reflexes, some muscle weakness, impaired proprioception. Affects balance and daily function.
• Moderately severe (40%): Significant motor and sensory involvement — marked weakness, loss of protective sensation, foot deformities, significant balance impairment, history of falls.
• Severe (60%): Pronounced muscle atrophy, near-complete sensory loss, severe functional limitation.

Critical point: Each affected extremity is rated separately. A veteran with moderate neuropathy in both lower extremities would receive 20% for the left leg and 20% for the right leg as separate ratings.

How to File This Secondary Claim

Follow these steps to file your peripheral neuropathy secondary claim:

1. Confirm your diabetes is service-connected. You must have an active service-connected rating for diabetes mellitus.

2. Obtain diagnostic testing. Request a nerve conduction study and/or EMG from a neurologist. Also gather your HbA1c history from your primary care provider.

3. Get a formal neuropathy diagnosis. Ensure your medical records contain a clear diagnosis specifying which extremities are affected and the type of neuropathy.

4. Obtain a nexus letter. Have a physician provide a written opinion linking your neuropathy to your diabetes through established metabolic mechanisms.

5. File VA Form 21-526EZ. Submit online at va.gov, by mail, or in person. File a separate claim for each affected extremity. Indicate each is secondary to your service-connected diabetes mellitus.

6. Describe the secondary relationship for each extremity. Example: “Peripheral neuropathy of the left lower extremity secondary to service-connected diabetes mellitus type II. Chronic hyperglycemia has caused nerve damage in the distal symmetric polyneuropathy pattern.”

7. Upload all supporting evidence. Include your nexus letter, NCS/EMG results, HbA1c records, treatment records, and personal statements.

8. Attend the C&P examination. The VA will schedule a peripheral nerves examination that includes sensory testing, motor strength testing, and reflex evaluation.

9. Track your claim through va.gov or by calling 1-800-827-1000.

C&P Exam Tips

The peripheral neuropathy C&P exam involves detailed neurological testing. Here is how to prepare:

• Report all affected extremities. If you have symptoms in your feet, hands, or all four extremities, make sure the examiner evaluates each one. Do not assume they will test everything automatically.
• Describe all symptoms. Report numbness, tingling, burning, shooting pain, loss of sensation, muscle weakness, cramping, balance problems, and any difficulty with fine motor tasks (buttoning shirts, gripping objects).
• Mention functional impacts. Describe how neuropathy affects your daily life — difficulty walking on uneven surfaces, inability to feel temperature or pain in your feet (creating safety concerns), dropping objects, and any falls you have experienced.
• Report your worst days. Neuropathy symptoms can fluctuate. Describe your symptoms during flare-ups, not just how you feel at the moment of the exam.
• Discuss foot care issues. If you have had foot ulcers, infections, or injuries you did not feel due to neuropathy, report these. They demonstrate the severity of sensory loss.
• List all medications. Report every medication for neuropathic pain, including gabapentin, pregabalin, duloxetine, and any topical treatments. Mention side effects that affect your functioning.
• Be honest during testing. The examiner will test sensation with monofilaments, pinprick, vibration, and temperature. They will test reflexes and muscle strength. Respond honestly to each test — do not try to perform better or worse than your actual capability.
• Bring your records. Have copies of your NCS/EMG results, HbA1c history, and nexus letter available.

Impact on Combined Rating

Peripheral neuropathy secondary to diabetes can dramatically increase your combined rating because each extremity is rated separately. This makes diabetic neuropathy one of the most impactful secondary claims in the VA system.

Example scenario — bilateral lower extremity neuropathy: A veteran has a 20% rating for diabetes and receives 20% for moderate neuropathy in each leg.

1. Combine bilateral lower extremity ratings: 20% + (20% of 80) = 36%
2. Apply bilateral factor (38 CFR § 4.26): 36% + 3.6% = 39.6%, rounded to 40%
3. Combine with diabetes: 40% (neuropathy) and 20% (diabetes)
4. Start with 40%: remaining = 60%
5. Apply 20%: 20% of 60 = 12, total = 52%, rounds to 50%

Example scenario — all four extremities affected: A veteran has 20% for diabetes, 20% for each lower extremity, and 10% for each upper extremity.

1. Combine bilateral lower extremities: 20% + (20% of 80) = 36%, bilateral factor = 39.6% = 40%
2. Combine bilateral upper extremities: 10% + (10% of 90) = 19%, bilateral factor = 20.9% = 21%
3. Combine all: start with 40%, apply 21% (21% of 60 = 12.6), total = 52.6%, then apply 20% diabetes (20% of 47.4 = 9.5), grand total = 62.1%, rounds to 60%

The jump from a standalone 20% diabetes rating to a combined 60% rating represents a major increase in monthly compensation. At the 60% level with dependents, the monthly benefit is significantly higher, and reaching higher combined ratings becomes more achievable with any additional conditions.

Furthermore, the VA’s note under DC 7913 (diabetes mellitus) states that compensable complications of diabetes are to be evaluated separately, meaning these neuropathy ratings are explicitly anticipated by the rating schedule.

For personalized guidance on your VA disability claim, consult a VA-accredited VSO, attorney, or claims agent.